Showing 2071-2080 of 3019 results for "".
- Prior Immunotherapy May Predict Response to PD-1 Checkpoint Blockadehttps://practicaldermatology.com/news/prior-immunotherapy-may-predict-response-to-pd-1-checkpoint-blockade/2461655/Responses to PD-1 checkpoint blockade in patients with advanced melanoma depend on whether or not they had previously received CTLA-4 blockade as well as other factors, new research suggests. Their findings, based on analysis of seven data sets generated over the past decade, which incl
- News You Can Use: BI Receives Permanent J-Code (J1747) for SPEVIGO Injectionhttps://practicaldermatology.com/news/news-you-can-use-bi-receives-permanent-j-code-j1747-for-spevigo-injection/2461649/The U.S. Centers for Medicare & Medicaid Services (CMS) has issued a permanent J-code (J1747) for Boehringer Ingelheim’s SPEVIGO (spesolimab-sbzo) Injection, indicated for the treatment of generalized pustular psoriasis (GPP) flares in adults. The J-code for SPEVIGO became eff
- It's Official: April Is the Coolest Month of the Yearhttps://practicaldermatology.com/news/its-official-april-is-the-coolest-month-of-the-year/2461642/April 2023 marks the first-ever CoolMonth, according to Allergan Aesthetics, an AbbVie company and the parent company of CoolSculpting Elite. Why April? A survey revealed 85% of people have a season in which they begin to think more about getting rid of stubborn body fat
- Lupus Research Alliance Collaborates with the FDA to Launch Public-Private Partnershiphttps://practicaldermatology.com/news/lupus-research-alliance-collaborates-with-the-fda-to-launch-public-private-partnership/2461641/The Lupus Research Alliance (LRA) announced the launched of Lupus Accelerating Breakthroughs Consortium (Lupus ABC), a public-private partnership. The goal of the partnership is to bring people with lupus together in collaboration with the F
- Researchers Discover Anti-Aging Potential in an Invasive Weedhttps://practicaldermatology.com/news/researchers-discover-anti-aging-potential-in-an-invasive-weed/2461638/The fruit of the cocklebur plant, which grows worldwide and is often considered a noxious weed, has antioxidant and anti-inflammatory components that could make it useful as a skin protectant, according to new research
- Burt's Bees Products Improve Redness, Pigmentation, and Reduce Acne-related PIHhttps://practicaldermatology.com/news/burts-bees-products-improve-redness-pigmentation-and-reduce-acne-related-pih/2461624/Burt’s Bees topical bakuchiol-containing sunscreen treats redness and pigmentation of photodamaged facial skin. What’s more, a cream containing Glycyrrhiza glabra (licorice root), Curcuma longa (turmeric root), and Terminalia chebula improves&n
- Molluscum Contagiosum Update: Two New Treatments Come Down the Pikehttps://practicaldermatology.com/news/molluscum-contagiosum-update-two-new-treatments-come-down-the-pike/2461621/Thanks to a busy pipeline, treating molluscum contagiosum may get easier. The U.S. Food and Drug Administration (FDA) accepted Novan’s New Drug Application (NDA) for Berdazimer Gel, 10.3% for the treatment of molluscum contagiosum with a Prescription Drug User Fee A
- Cetaphil Celebrates Sensitive Skin with a Month of Skin Science Educationhttps://practicaldermatology.com/news/cetaphil-celebrates-sensitive-skin-with-a-month-of-skin-science-education/2461610/Cetaphil is ringing in the 2nd Annual Sensitive Skin Awareness initiative globally with a month of skin science education. Activating under the brand's campaign, "We Do Skin. You Do You," the global science effort will arm consumers with guidance on how to i
- Health Canada Approves Candela's Picoway for Melasmahttps://practicaldermatology.com/news/health-canada-approves-candelas-picoway-for-melasma/2461608/Health Canada has granted Candela’s PicoWay laser system licensing for expanded indications, including the melasma, lentigines, café au lait macules (CALMs), and Nevus of Ota. The US Food and Drug Administration gave the device a similar same nod in Oct
- Long-term, Systemic Antibiotic Use for Teen Acne May Promote Fat Accumulationhttps://practicaldermatology.com/news/long-term-systemic-antibiotic-use-for-teen-acne-may-promote-fat-accumulation/2461603/Long-term antibiotic use for the treatment of adolescent acne disrupts the healthy gut microbiome, leading to changes in liver metabolism that promotes the accumulation of central fat, a new study shows. Around 25 percent of adolescents require systemic antibiotics, such as minocycline,